Month: October 2021

RT @eyewireplus: .@BauschLomb and @clearsidebio announced that the FDA has appro…

RT @eyewireplus: .@BauschLomb and @clearsidebio announced that the FDA has approved Xipere (triamcinolone acetonide injectable suspension)… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @OTEurope: Triamcinolone acetonide for suprachoroidal injection for treatment…

RT @OTEurope: Triamcinolone acetonide for suprachoroidal injection for treatment of uveitic macular oedema approved by US FDA #Ophthalmolog… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @Genes_MDPI: Genes EBM @ThomasCiullaMD has been interviewed by @retinapodcast…


RT @Genes_MDPI: Genes EBM @ThomasCiullaMD has been interviewed by @retinapodcast on career development and advances in retina therapeutics.…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: FDA Approval of XIPERE™ (triamcinolone acetonide injectable …

RT @ThomasCiullaMD: FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for #Suprachoroidal Use for the Treatment of Ma… Source by Thomas Ciulla, MD, MBA Return to main website.

FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for #Sup…

FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for #Suprachoroidal Use for the Treatment of Macular Edema Associated with #Uveitis, the first product approved for injection into the suprachoroidal space. #eye #retina https://t.co/R2wcsmOZP4 Source by Thomas Ciulla, MD, MBA Return to main website.

@drmarirodriguez @RetinaPodcast Thanks so much for your kind comments!…


@drmarirodriguez @RetinaPodcast Thanks so much for your kind comments!


Source by Thomas Ciulla, MD, MBA

Return to main website.

Honored to have been interviewed by @retinapodcast on research, roles in industr…

Honored to have been interviewed by @retinapodcast on research, roles in industry, and innovations in retinal therapeutics and delivery… #eye #retina #clinicalresearch #genetherapy #suprachoroidal https://t.co/H4aPQAbPPH Source by Thomas Ciulla, MD, MBA Return to main website.

Just published: Retinal Physician-Current Clinical Trials in Diabetic Macular Ed…

Just published: Retinal Physician-Current Clinical Trials in Diabetic Macular Edema Innovative therapies with durability & novel mechanisms include pan-VEGF Inhibitors, Ang2 inhibitors, plasma kallikrein inhibitors & anti-integrin therapies. #eye #retina https://t.co/lAvvtLQKfS Source by Thomas Ciulla, MD, MBA Return to main website.

Congrats to colleagues with OIS & #ASRS presentations on #suprachoroidal deliver…


Congrats to colleagues with OIS & #ASRS presentations on #suprachoroidal delivery via the SCS Microinjector: clinically studied therapies – a corticosteroid, CLS-AX TKI, #genetherapy, & virus-like drug conjugate for macular edema, #AMD, #diabeticretinopathy, & choroidal melanoma https://t.co/iRHVakqmeO


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @RetinalPhys: Attending @asrsdocs Retina Specialists meeting in San Antonio? …

RT @RetinalPhys: Attending @asrsdocs Retina Specialists meeting in San Antonio? Don’t miss Dr. Dennis Marcus’ presentation, Suprachoroidal… Source by Thomas Ciulla, MD, MBA Return to main website.